- Home
- PHIO vs COSM Comparison
PHIO vs COSM Comparison
Compare PHIO & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- COSM
- Stock Information
- Founded
- PHIO 2011
- COSM 2009
- Country
- PHIO United States
- COSM United States
- Employees
- PHIO N/A
- COSM N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- PHIO Health Care
- COSM Health Care
- Exchange
- PHIO Nasdaq
- COSM Nasdaq
- Market Cap
- PHIO 13.7M
- COSM 12.3M
- IPO Year
- PHIO N/A
- COSM 2013
- Fundamental
- Price
- PHIO $2.31
- COSM $1.04
- Analyst Decision
- PHIO Strong Buy
- COSM
- Analyst Count
- PHIO 3
- COSM 0
- Target Price
- PHIO $10.67
- COSM N/A
- AVG Volume (30 Days)
- PHIO 161.3K
- COSM 1.2M
- Earning Date
- PHIO 11-13-2025
- COSM 11-13-2025
- Dividend Yield
- PHIO N/A
- COSM N/A
- EPS Growth
- PHIO N/A
- COSM N/A
- EPS
- PHIO N/A
- COSM N/A
- Revenue
- PHIO N/A
- COSM $55,093,442.00
- Revenue This Year
- PHIO N/A
- COSM $28.14
- Revenue Next Year
- PHIO N/A
- COSM N/A
- P/E Ratio
- PHIO N/A
- COSM N/A
- Revenue Growth
- PHIO N/A
- COSM N/A
- 52 Week Low
- PHIO $0.97
- COSM $0.28
- 52 Week High
- PHIO $9.79
- COSM $1.28
- Technical
- Relative Strength Index (RSI)
- PHIO 54.93
- COSM 57.89
- Support Level
- PHIO $2.28
- COSM $0.92
- Resistance Level
- PHIO $2.45
- COSM $1.27
- Average True Range (ATR)
- PHIO 0.12
- COSM 0.11
- MACD
- PHIO 0.02
- COSM -0.01
- Stochastic Oscillator
- PHIO 54.72
- COSM 40.49
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.